KMT2A and acute myeloid leukemia: The detailed splicing patterns of three representative oncogenic fusions are illustrated in Fig. 4d, where alternative usage of exon 10 in KMT2A is clearly observed in both KMT2A-rearranged AML tumors and AML tumors without KMT2A fusions.